MedTrace Logo

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

NCT05836181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-05-01

No results posted yet for this study

Summary

Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.

Conditions

  • Eye Movement Desensitization and Reprocessing Intervention
  • Blood Pressure
  • Heart Rate Variability
  • Anxiety

Interventions

BEHAVIORAL

Eye Movement Desensitization and Reprocessing

Effects of Eye Movement Desensitization and Reprocessing on Anxiety, Depression, Quality of Life, Blood Pressure and Heart Rate Variability in Patients with Hypertension.

Sponsors & Collaborators

  • Miao-Yi Chen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-01
Primary Completion
2016-12-10
Completion
2016-12-28

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05836181 on ClinicalTrials.gov